Envista Holdings Corporation will release its financial results for the fourth quarter of 2023 on Wednesday, February 7, 2024. A conference call discussing these results is scheduled for the same day at 2:00 PM PT and is expected to last approximately one hour.
The call, along with an accompanying slide presentation, will be webcast on the “Investors” section of Envista’s website, www.envistaco.com. A replay of the webcast will be available shortly after the presentation concludes and will remain accessible for one year. To join the conference call, dial 800-225-9448 within the U.S. or +1 203-518-9708 outside the U.S. a few minutes before 2:00 PM PT, and reference conference ID #7305894.
Prior to the conference call, Envista’s earnings press release, webcast slides, and other related presentation materials will be posted on the “Investors” section of their website. These materials will be available both before and after the call.
About Envista Holdings Corporation
Envista is a global family of over 30 trusted dental brands, such as Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to collaborate with professionals in improving lives. Envista assists its customers in delivering optimal patient care through leading dental consumables, solutions, technology, and services. The comprehensive portfolio, covering dental implants, orthodontics, and digital imaging technologies, addresses a broad spectrum of dentists’ clinical needs for diagnosing, treating, and preventing dental conditions, as well as enhancing the aesthetics of the human smile.
Built on the proven Envista Business System (EBS) methodology, with an experienced leadership team and a strong culture of continuous improvement, innovation, and customer focus, Envista is well-positioned to meet the end-to-end needs of dental professionals worldwide. Envista stands as one of the largest global dental products companies, holding significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.